Millions of Americans live with pain that can often persist for years. Current treatment options that include opioids and nonsteroidal anti-inflammatory drugs (NSAIDs) are limited in their clinical effectiveness. In addition, there are important undesirable side effects and safety risks associated with the available treatments for acute and chronic pain, not the least of which is the expanding epidemic of prescription pain medicine misuse and abuse. Read More
The Generating Antibiotic Incentives Now (GAIN) section of the Food and Drug Administration Safety and Innovation Act (FDASIA) lists some pathogens that can qualify antibiotics for new incentives, but left open the possibility of adding additional pathogens to the list. Read More
When Science magazine published its annual breakthrough of the year issue last week, one of the contenders for the top scientific advance of the year – an honor that went to the discovery of the Higgs boson – was a new genome editing technique, transcription activator-like effector nucleases or TALENs. Read More
